Original BioMedicals Co., Ltd.

Original BioMedicals develops drugs in Taiwan. The company develops OBM-A01, a radiation injury prevention and therapeutic drug for the treatment of acute radiation injuries Including nuclear radiation and solar radiation exposure in space. Its portfolio also includes OBM-B01, a cyanide compound drug for protection against toxic gases from fires, CCM-CL, a cyclic polypeptide antibiotic, and Iron Dextran, an injection for the treatment of iron deficiency NE (vitamin C+E) and NE Butorphanol, as well as technical services. Original BioMedicals Co., Ltd. was incorporated in 2011 and is based in Tainan City, Taiwan.